Latest news in cancer
Non-invasive treatment option for advanced metastatic gastric cancer
Recently, the Global Oncologist Network reported that a patient with advanced cardia cancer liver metastasis has successfully survived for three years after...
NCCN treatment guidelines for advanced gastric cancer
The 2016 NCCN Clinical Guidelines for Gastric Cancer updated the systemic treatment plan for metastatic or locally advanced gastric cancer in the first edition...
CRITICS study – ASCO 2016
The 2016 American Conference of Clinical Oncology (ASCO) is about to be held in Chicago as one of the most talked about academic conferences in the field of...
Ramucirumab prolongs the survival of advance gastric cancer patients
According to the results of a large multicenter clinical trial led by scientists at the Dana Faber Cancer Research Center, after standard treatment fails, a...
PD-L1 inhibitors initially show positive results in advanced gastric cancer
Immunotherapy and cancer treatment In recent years, the popularity of immunotherapy in the field of oncology is continuing to rise. Lancet Oncol published the...
Ramucirumab in treatment of gastric cancer
According to statistics, patients with gastric cancer treated in the United States, Europe, and Japan are often recommended to use ramucirumab in combination...
Drug resistance in non-small cell lung cancer
What to do about drug resistance of non-small cell lung cancer targeted drugs, you want to know here Lung cancer is the cancer with the highest morbidity and...
PD-1 and PD-l1 treatment of lung cancer
Lung cancer immunotherapy, lung cancer immunotherapy, lung cancer PD-1 treatment, and lung cancer PD-L1 treatment are all you want to know. In the past two...
Brigatinib for ALK-positive crizotinib resistant non-small cell lung cancer
Dong-Wan Kim scholars from the Seoul National University Hospital in South Korea will give an oral report on the special meeting of metastatic non-small cell...
Proton therapy is the best option for lung cancer patients
Lung cancer and proton therapy The lungs are adjacent to some of the most sensitive and important organs and tissues, including the heart, esophagus, and...
Radiofrequency ablation treatment for lung cancer patients
Lung cancer is one of the most common causes of human death due to tumors, and its morbidity and mortality rate have ranked first in cities. The pathology is...
Afatinib is more effective than gefitinib in treating non-small cell lung cancer
The results of the LUX-Lung 7 study show that a head-to-head Phase IIb clinical study compared afatinib and gefitinib in the treatment of tumors with EGFR...
NCCN Guidelines for Small Cell Lung Cancer V2.2016
The second edition of the 2016 NCCN Guidelines for Small Cell Lung Cancer (V2.2016) mainly updates the following parts based on V2.2015: Lung cancer...
Nivolumab plus Ipilimumab as first-line treatment for stage IV non-small cell lung cancer
Registration: ClinicalTrials.gov Last updated: January 25, 2016 Main ID: NCT02659059 Registration Date: January 15, 2016 Main sponsor: Bristol-Myers Squibb...
Third-generation EGFR targeted drug Tagrisso for lung cancer treatment
The US FDA today approved the official launch of AstraZeneca’s new drug AZD9291! The trade name and common name of AZD9291 are called Tagrisso or...
Precision medicine for lung cancer
Lung cancer problem Perhaps it is because of the direct feeling of the respiratory system. As the haze continues, we feel more and more people suffering from...
EGFR monoclonal antibody Portrazza for advanced lung squamous cell carcinoma
The US Food and Drug Administration (hereinafter referred to as FDA) approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin in the...
The safety and efficacy of MPDL3280A combined with platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer
MPDL3280A, which retains the PD-L2 / PD-1 interaction, potentially reduces autoimmune lung toxicity, and has a good effect on advanced NSCLC. Platinum-based...
Treatment of central lung cancer with speed knife
Treatment of non-small cell lung cancer The treatment of lung cancer mainly uses surgery, radiotherapy and chemotherapy, and surgery is still the most...
Non-small cell lung cancer with brain metastasis and ALK targeted therapy
Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival...
Iressa Trocaine in the treatment of EGFR-mutated non-small cell lung cancer
Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform...
Genetic testing guides the treatment of ALK positive lung cancer
Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform...
EDGE non-invasive tumor radiosurgery for lung cancer
Cancer related deaths in United States The American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer...
Multiple genetic testing of lung cancer tumors
A study published online in the Journal of the American Medical Association on May 21st showed that multiple genetic tests of lung cancer tumors can help...
Stereotactic radiotherapy for lung cancer that cannot be surgically removed
Stereotactic body radiation therapy Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR). Since its application...
Instructions for using Opdivo -nivolumab for patients with non-small cell lung cancer
Opdivo has been listed in the United States for the treatment of lung cancer. Many cancer patients cannot go abroad for treatment for various reasons. Consult...
Anti cancer drugs approved between 2005 to 2014
Approved drugs by ASCO from 2005 to 2014 Since ASCO published its first clinical cancer progress report in 2005, it has witnessed solid and determined progress...
Anti-cancer drug Opdivo becomes the first PD-1 drug to cure lung cancer
On January 13, 2015, Huanyu Dakang Medical News pharmaceutical giant Squibb Company ushered in a good start in 2015. The anti-cancer immunotherapy drug...
Lung cancer case study and clinical trial
1. Diagnosis and first treatment of lung cancer Patient Lu was diagnosed with lung adenocarcinoma and lymph node metastasis on August 26, 2005. A left lower...
Classification of lung adenocarcinoma and surgical perspective of lung cancer
1. Individualized scope of lung parenchymal resection Since the 1960s, regardless of tumor size, anatomical lobectomy has become the standard for surgical...
Liver cancer treatment in 2023
Burden of liver cancer Liver cancer is a common malignant tumor accounting for more than half of the global liver cancer. The onset of hepatocellular...
Latest immunotherapy in liver cancer treatment
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is...
NK Cell immunotherapy in advanced liver cancer cases
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s,...
Proton therapy prolongs overall survival of hepatocellular carcinoma
Proton therapy for liver cancer, prolonged overall survival of patients with hepatocellular carcinoma proton therapy Hepatocellular carcinoma is the most...
Laser technology can identify and destroy cancer cells circulating in the blood
Speaking of tumors is always daunting, but in fact, as long as it stays in place, it is not so terrible, we can just uproot it. The malignant tumor is...
Cell immunotherapy for prevention, recurrence, and metastasis of liver cancer
The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.